Robert Hamilton Pierce
Impact in
- Immunology top 0.1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- Psoriasis: Treatment and Pathogenesis
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 51
- Immunotherapy and Immune Responses 21
- Immune Cell Function and Interaction 17
- Immune cells in cancer 9
- T-cell and B-cell Immunology 8
- Oncology 49
- Cancer Immunotherapy and Biomarkers 23
- CAR-T cell therapy research 21
- Co-authors
- Ian Nicholas Crispe (11 shared papers)Nelson Fausto (11 shared papers)Terrill K. McClanahan (8 shared papers)Scott P. Turner (5 shared papers)Leonidas G. Koniaris (7 shared papers)Robert A. Kastelein (4 shared papers)Teresa A. Zimmers (6 shared papers)Jeff Grein (4 shared papers)
- Journals
- Clinical Cancer Research (7 papers)American Journal Of Pathology (7 papers)Cancer Immunology Research (6 papers)Hepatology (6 papers)The Journal of Immunology (5 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Robert Hamilton Pierce
121 papers receiving 18.3k citations
Robert Hamilton Pierce's Hit Papers
Peers
Comparison fields: 5 of 147
- Immunology 7.9k
- Oncology 9.2k
- Hepatology 833
- Cancer Research 1.1k
- Rheumatology 920
Countries citing papers authored by Robert Hamilton Pierce
This map shows the geographic impact of Robert Hamilton Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hamilton Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hamilton Pierce more than expected).
Fields of papers citing papers by Robert Hamilton Pierce
This network shows the impact of papers produced by Robert Hamilton Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hamilton Pierce. The network helps show where Robert Hamilton Pierce may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Hamilton Pierce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-1 blockade induces responses by inhibiting adaptive immune resistance Hit paper breakdown → | 2014 | 5527 |
| 2 | IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells Hit paper breakdown → | 2012 | 896 |
| 3 | Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 Hit paper breakdown → | 2018 | 790 |
| 4 | Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors Hit paper breakdown → | 2015 | 672 |
| 5 | Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors Hit paper breakdown → | 2017 | 629 |
| 6 | Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research Hit paper breakdown → | 2017 | 553 |
| 7 | Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC Hit paper breakdown → | 2017 | 469 |
| 8 | 2016 | 432 | |
| 9 | Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer Hit paper breakdown → | 2017 | 398 |
| 10 | 2009 | 395 | |
| 11 | 2007 | 283 | |
| 12 | 2019 | 281 | |
| 13 | 2020 | 275 | |
| 14 | 2004 | 266 | |
| 15 | 1998 | 241 | |
| 16 | 2018 | 237 | |
| 17 | 2021 | 193 | |
| 18 | 2008 | 192 | |
| 19 | 2019 | 191 | |
| 20 | 2009 | 188 |
About Robert Hamilton Pierce
Robert Hamilton Pierce is a scholar working on Immunology, Oncology, Hepatology, Biotechnology and Pharmacology, having authored 124 papers that have together received 18.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (23 papers), CAR-T cell therapy research (21 papers), Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (17 papers), Liver physiology and pathology (11 papers), Immune cells in cancer (9 papers), Microbial Inactivation Methods (9 papers) and T-cell and B-cell Immunology (8 papers). The work is most often cited by research in Immunology (7.9k citations), Oncology (9.2k citations), Hepatology (833 citations), Cancer Research (1.1k citations) and Rheumatology (920 citations). Robert Hamilton Pierce has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Ian Nicholas Crispe, Nelson Fausto, Terrill K. McClanahan, Scott P. Turner, Leonidas G. Koniaris, Robert A. Kastelein, Teresa A. Zimmers, Jeff Grein, David J. Topham and Edward P. Bowman. Their work appears in journals such as Clinical Cancer Research, American Journal Of Pathology, Cancer Immunology Research, Hepatology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.